Scailyte

About:

True precision medicine through single-cell science

Website: http://www.scailyte.com

Twitter/X: scailyte

Top Investors: Verve Ventures, Venture Kick, Innosuisse, Hemex, MassChallenge

Description:

Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.

Total Funding Amount:

$15.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2017-06-19

Contact Email:

contact(AT)scailyte.com

Founders:

Daniel Sonnleithner, Dennis Gohlsdorf, Manfred Claassen, Peter Nestorov

Number of Employees:

11-50

Last Funding Date:

2023-12-04

IPO Status:

Private

© 2024 MyAiNote.com